Bacterial conversion of 4-chlorobiphenyl(4-CB) usually proceeds through a pathway involving an initial oxidation of the unsubstituted ring in the 2,3 position followed by a 1,2 meta-cleavage. The meta-cleavage product (MCP) is converted through a single hydrolysis step into chlorobenzoic acid. However, several other acidic metabolites that were not expected as part of this pathway have already been described. In this paper, we used strains of Pseudomonas putida carrying cloned genes from Pseudomonas testosteroni B-356 that are involved in polychlorinated biphenyl (PCB) degradation to demonstrate that several acidic metabolites found in the culture media of various bacteria grown in the presence of 4-CB result from alternative novel bioconversion pathways of MCP. The degradation products of MCP through these pathways were identified as analogues with saturated or shorter side chains or as 4-chlorophenyl-2-picolinic acid; pathways leading to their formation are proposed.
Introduction
Polychlorinated biphenyls (PCBs) are very resistant to biodegradation. However, many bacterial strains able to degrade lower chlorinated PCBs have now been described (Furukawa & Matsumura, 1976; Bedard et al., 1986; Furukawa & Miyazaki, 1986; Khan et al., 1988; Parsons et al., 1988 ; Mass6 et al., 1984; Ahmad et al., 1990) . The postulated steps for the conversion of such PCBs into the corresponding chlorobenzoic acids are illustrated in Fig. 1 . Analysis of metabolites generated in the growth medium of bacteria grown in the presence of biphenyl or PCBs and cloning of the genes involved in this pathway have provided evidence that the degradation is initiated by the hydroxylation of the unsubstituted (or less substituted) ring in the 2,3 position followed by a 'meta' 1,2 fission of the ring to generate the acidic meta-cleavage product (MCP).
However, a number of questions still remain to be answered since there are many other metabolites in the culture medium of bacteria grown in the presence of Abbreviations: BP, biphenyl ; 4-CB, 4-chlorobiphenyl ; MCP, metucleavage product [of 4-CB, viz. 2-hydroxy-6~xo-6-(4'-chlorophenyl)-hexa-2,4-dienoic acid]; PCB, polychlorinated biphenyl; 2,3-0H-4'-CBP, 2,3-dihydroxy-4'-chlorobiphenyl; BSTFA, N,O-bis(trimethy1-sily1)trifluroacetamide ; TIC, total ion chromatogram; TMS, trimethylsilyl. Other abbreviations are listed in Table 2. biphenyl, c hloro bip hen yls or hydrox ybip hen yls (Mass& et al., 1984; Yagi & Sudo, 1980; Bedard et al., 1986; Takase et al., 1986; Sondossi et al., 1991) that one would not expect to find if the proposed pathway was the only one operating. These unexpected metabolites were described either as saturated analogues of MCP or benzoyl compounds substituted with an aliphatic side chain of five, four or three carbon atoms instead of six as in the MCP. The presence of some acidic metabolites with shorter side chains has been used as evidence for 3,4-dihydroxylation of the biphenyl ring (Yagi & Sudo, 1980; Mass6 et al., 1984; Bedard et al., 1986) . Although 3,4-di hydro-3,4-di hydroxyc hlorobiphenyl has indeed been detected in some bacterial cultures grown in the presence of chlorobiphenyls (Massk et al., 1989; Nadim et al., 1987) , the direct formation of these acidic compounds from 3,4-dihydroxybiphenyls has never been demonstrated. It is, therefore, possible that at least some of these metabolites may have been dead-end products generated from the degradation of unstable intermediates of the pathway or that they may have been derived chemically during the procedure followed to extract the metabolites from the growth medium.
Although it is generally believed that the bphD gene controls the single final hydrolysis step between the MCP of 4-chlorobiphenyl(4-CB), i.e. 2-hydroxy-6-0x0-6-(chlorophenyl)hexa-2,4-dienoic acid, and 4-chlorobenz- oate (4-CBA), alternative pathways involving stepwise oxidative decarboxylation of the aliphatic side chain of the MCP have also been proposed to explain the formation of some of the benzoyl compounds with short aliphatic side chains (Masse et al., 1984 (Masse et al., , 1989 . Since the bphD gene product (s) has not yet been studied in detail, this last question still remains unanswered. We have recently cloned, in Pseudomonas putida KT2440, the whole series of genes involved in the biphenyl/chlorobiphenyl (BP/PCB) catabolic pathway from Pseudomonas testosteroni strain B-356. Two clones were isolated, P. putida DA1, which is able to transform 4-CB directly into 4-CBA with almost no accumulation of any other metabolite, and P. putida DA2, which accumulates many acidic metabolites including several that are not expected through the pathway shown in Fig. 1 (Ahmad et al., 1990) . All the enzymes of this pathway showed a relaxed specificity toward substrate so that the pathway is also able to degrade hydroxybiphenyls and hydroxychlorobiphenyls. The degradation of these substrates by P. putida DA2 gave similar results as with 4-CB, whereby saturated and unsaturated meta-cleavage compounds were detected as well (Sondossi et al., 1991) . Sangodkar et al. (1988) have pointed out the importance of mutational studies in the determination of the catabolic pathways rather than simple analysis of compounds accumulating in the growth medium. In the work described in this paper, we used strains DAl and DA2, along with a few of the subclones derived from them which carried only part of the pathway, to study the origin of some of these unexpected acidic metabolites, and the pathways for their formation are proposed. To achieve this goal, 4-CB was used as a model compound since bacterial metabolites produced during its degradation have been studied and characterized extensively in our laboratory (MassC et al., 1984 (MassC et al., ,1989 , thus enabling us to identify all the metabolites produced.
Methods
Bacterial strains, culture media and chemicals. The bacterial strains used in this study and their phenotypic characteristics are listed in Table 1 . The strains were kept lyophilized in bovine serum or frozen in 1 % (w/v) dimethyl sulphoxide and they were transferred into minimal medium no. 30 (MM 30) (Sylvestre, 1980) or LB broth (Maniatis et al., 1982) containing the appropriate selective agents for propagation. The 4-CB used in this study was from Aldrich; 4-CB metabolites used as substrates were produced as described below; all other chemicals and solvents were of the highest purity commercially available.
Production of 2,3-dihydroxy-4-chlorobiphenyl(2,3-OH-4-CBP). This compound was produced using P . putida DA26 1, which accumulates this intermediate in the growth medium (unpublished result). Cells from cultures grown overnight in 1 litre of MM 30 plus 1% (w/v) glucose and 150 pg streptomycin (Sm) ml-* were centrifuged, washed in MM 30 and transferred into the same volume of MM 30 plus 1 % glucose, 150 pg Sm ml-1 and 0.1 % (w/v) 4-CB. The cultures were incubated with shaking at 29 "C for 12-18 h, the cells were spun down and the supernatant was extracted with ethyl acetate. The extract was Bioconversion of 4-CB rneta-cleavage product 1 377 SmR, streptomycin resistance; SuR, sulphathiazole resistance; Mob+, can be mobilized; SpR, spectinomycin resistance; bphA, B, C and D are genes involved in biphenyl degradation (see Fig. 1 ).
concentrated by evaporation to yield 50-1 00 mg product per g substrate. The 2,3-OH-4'-CB was purified by HPLC using a Whatman C-18 semi-preparative column that was eluted with methanol/acetonitrile/water (8 : 17 : 75, by vol.) applied as a gradient to reach a final concentration of methanol/acetonitrile (32 : 64, v/v) in 20 min.
Production of meta-cleavage products derived from 4-CB. The metacleavage product 2-hydroxy-6-oxo-6-(4'-chlorophenyl)hexa-2,4-dienoic acid (the abbreviation MCP is hereafter used to refer specifically to this compound) was produced from Escherichia coli JM105(pDA25 l), bearing the bphC gene. E. coli JM105(pDA251) was grown overnight into LB broth containing ampicillin (100 pg ml-l) and IPTG (50 pg ml-l) to induce the enzyme. The cells were harvested, washed in 0.1 Mphosphate buffer pH 7.2, resuspended in the same buffer to an OD,,, of 1, and then ultrasonified with a Braunsonic sonifier. The cell extracts were centrifuged at 20000g for 20 min, and adjusted to a protein concentration of approximately 2 mg ml-l using the Lowry protein assay method (Stauffer, 1975) . A 25 ml volume of this preparation was used directly as a reaction mixture to which 0.5 pmol substrate (2,3-OH-4-CB) was added to initiate the reaction. The substrate was almost _.
completely converted to MCP when the reaction mixture was incubated for 1-2 h at 37 "C, producing 15-20 nmol MCP ml-l. The reaction mixture was extracted twice with ethyl acetate at neutral pH to remove the residual substrate and then three times at pH 4.0. Gas chromatographic (GC) analysis of the acidic ethyl acetate extract showed two major peaks at approximately 34.9 min which were isomers of MCP. No other transformation products from the substrate were detected.
Reduced MCP derivatives with mono-and di-saturated aliphatic side chains, 2-hydroxy-6-oxo-6-(4'-chlorophenyl)hex-4-enoic acid (MS-MCP) and 2-hydroxy-6-oxo-6-(4'-chlorophenyl)hexanoic acid (DS-MCP) respectively, were obtained as the degradation products of 4-CB when P. putida strain DA2 was grown in MM 30 in the presence of Sm (150 pg ml-I), 1 % glucose and 0.1 % 4-CB. Cultures (25 ml in 125 ml Erlenmeyer flasks) were incubated with shaking for 5 d, then filtered through glass wool to remove residual solids of 4-CB and centrifuged. The supernatant was extracted with ethyl acetate first at neutral pH and then at pH 3. The pH 3 extract contained MS-MCP and DS-MCP as major products. Approximately 5-1Opg of combined MCP, MS-MCP and DS-MCP was obtained for each 1 mg of 4-CB added to the medium. Although the yields were low, the amounts produced were sufficient to test for their bioconversion. The pH 3 extract was either used as such or was purified further by HPLC using a Whatman semipreparative C 18 column eluted with methanol/acetonitrile/water as described above. Under these conditions, MS-MCP and DS-MCP were separated as two distinct peaks.
Biotransformation of the metabolites from the 4-CB degradation pathway. The biotransformation of 4-CB metabolites was assayed in growing cultures or resting cell suspensions of P. testosteroni B-356 and P. putida DA1, DA2 and KT2440. MM 30 containing the substrate was inoculated with a high-density cell suspension to give a final concentration of approximately 1 x lo9 cells ml-l, and the culture was incubated with shaking at 29 "C for the duration of the experiment. In all cases, appropriate control experiments were run in parallel. At the end of the incubation period, the metabolites were extracted with ethyl acetate first at neutral pH and then at pH 3.0 or 4.0 as described previously (Masst et al., 1984 (Masst et al., , 1989 . The extracts were analysed as trimethylsilyl (TMS) derivatives by G C and gas chromatography/mass spectrometry (GC/MS) using the procedure described by Ahmad et al.
(1 990).
Analysis of acidic metabolites of 4-CB produced by P . putida DA2 P . putida strain DA2, carrying plasmid pDA2, is able to transform 4-CB as well as other chlorinated (Ahmad et al., 1990) or hydroxylated biphenyl (Sondossi et al., 1991) analogues into the corresponding acidic derivatives. pDA2 was obtained by cloning, in the vector plasmid pPSA842, a 25 kbp DNA fragment of P . testosteroni strain B-356 (Ahmad et al., 1990) . pDA2 does not carry the bphD gene which is required to carry out the last step 1 Metabolites were identified as TMS derivatives.
of the pathway, i.e. transformation of MCP into the corresponding benmic acid (Ahmad et al., 1990) . The acidic metabolites listed in Table 2 were produced when 4-CB was added to resting cell suspensions of strain DA2; they were identified using GC/MS analysis, by comparison with published data from our laboratory and mass spectral characteristics of authentic reference compounds (Mass6 et al. , 1989, 1984) . Except for metabolites I (4-CBA) and 9 (MCP), all other metabolites were not expected as being part of the BP/PCB degradation pathway shown in Fig. I . These metabolites were not exclusively produced by strain DA2 since they were also detected in cultures of the parental strain B-356 grown on 4-CB. Moreover, these metabolites (CCA, CBP, CBB, OHCBB, MS-MCP and DS-MCP) have also been detected in the growth medium of other bacterial strains, including strain B-206 (Mass6 et al., 1989) , Achromobacter sp. strain B-218 and Bacillus brevis strain B-257 (Mass6 et al., 1984) . Thus many PCB-degrading bacteria produce these unexpected metabolites. However, it is not clear whether these metabolites are part of other existing unknown pathways for PCB degradation, are dead-end metabolites, or are metabolites generated through spontaneous reactions from intermediates of the pathway during their extraction from the medium. We felt that strain DA2, and other clones from our collection, that carry selected genes for the BP/PCB degradation pathway, could help understand the origin of these acidic metabolites. The total ion chromatogram (TIC) profile in Fig. 2 gives an idea of the relative proportion of the acidic metabolites produced from 4-CB by resting cell suspensions of strain DA2. The major metabolites were MS-MCP (metabolite 7) and DS-MCP (metabolite 8). Younger cultures (1-6 h old) contained more MS-MCP while older cultures (18-72 h old) contained almost exclusively DS-MCP. The other benzyl or benzoyl metabolites with a shorter acidic aliphatic side chain, viz. CCA, CBP, CBB and OHCBB, were detected in lesser amounts. Metabolite 9 (MCP) was always found in trace amounts. Therefore, it appeared that MCP was either rapidly converted by the cells or transformed during extraction.
Strain DA2 was unable to grow on 4-CB. However, interestingly, when this strain was grown on MM 30 in the presence of 4-CB plus glucose, the production of other acidic metabolites seemed to be almost totally inhibited, and only MS-MCP and DS-MCP plus traces of MCP were produced. This is an important observation, since it allowed us to produce the two saturated forms of MCP for further assays required to study their biotransformation pathways.
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Production of MCP from 2,3-dihydroxy-4'-chlorobiphenyl
When 2,3-OH-4'-CBP was fed to resting cell suspensions of P . putida DAl or DA2, or P. testosteroni B-356, essentially the same results were obtained as with 4-CB. In all these cultures, the medium immediately turned yellow after addition of 2,3-OH-4'-CBP, indicating the production of MCP. While cultures of strain DA2 remained yellow, with no change in A434 for several hours, the colour rapidly disappeared and large amounts of 4-CBA were produced in cultures of strains B-356 and DA 1, which carry the whole series of genes required for the transformation of 4-CB into 4-CBA (Ahmad et al., 1990). However, in suspensions of strain DA2, only trace amounts of MCP were detected by GC/MS, and MS-MCP and DS-MCP were the major metabolites. Because of the low copy number and the large size of pDA2, the gene bphC was not very well expressed in E. coli DHI(pDA2). However, E. coli DA251 carrying a 3.7 kbp SmaI fragment of pDA2 corresponding to the bphC gene subcloned in pUC18, was able to rapidly convert 2,3-OH-4'-CBP to MCP. Cell-free extracts of E. coli DA251 were able to transform 20 nmol ml-l of the substrate into almost stoichiometric amounts of MCP during 1 h of incubation at 37 "C. Although we noticed, as will be discussed later, that MCP was not stable for long periods in aqueous solutions, it became evident that . "b Table 2. MCP was not degraded or transformed into its saturated analogues during extraction with ethyl acetate since the expected amounts of MCP could be extracted from the medium in the above-mentioned experiments.
Further transformation of MCP
The TICS in Fig. 3 (a, b) show that P . putida DA 1 rapidly transformed MCP into 4-CBA, while P . putida DA2, which does not bear the bphD gene, transformed MCP into MS-MCP and DS-MCP. In these experiments, the conversion was not stoichiometric. In the case of DA1, when 0.5 pmol MCP was added to 10 ml medium, only 150-200 nmol4-CBA was produced within 30 min, while no substrate could be re-extracted from the medium. For strain DA2, only 40% of the added substrate was recovered as DS-MCP plus small amounts of other acidic metabolites. These data are not surprising, considering, as we will discuss later, that MCP is also chemically converted into molecular species (probably polymers) that are not detected in GC/MS analysis. However, the important point about this experiment is that the host strain P. putida KT2440 also converted MCP into MS-MCP and DS-MCP (Fig. 3c) , which provided evidence that the genes controlling further reduction of MCP are not carried on plasmid pDA2 and that they are not part of the BP/PCB degradation pathway. In fact, a 2-hydroxy-6-oxo-6-phenylhex-2,4-dienoic acid-reducing enzyme has recently been purified from a BP degrading Pseudomonas cruciviae (Omori et al., 1986a) . However, this enzyme did not appear to play any specific role in BP degradation.
The data presented in Fig. 3 were obtained from cultures grown in broth medium containing glucose in were also produced from MCP by both P. putida KT2440 and DA2 and the proportions of metabolites were also about the same in both strains. Therefore, the acidic compounds with a shorter aliphatic side chain that were produced when strain DA2 was grown in the presence of 4-CB (Fig. 2) appeared to be generated from MCP or its saturated analogues through biotransformation reactions involving enzymes that are not related to the main BP/PCB pathway. These enzymes appear to be under some glucose-mediated control in P. putida.
Conversion of MCP into metabolite 6
The case of metabolite 6 is special since it is a nitrogencontaining derivative. This metabolite was detected in cultures of strains DA2 (Fig. 2) and B-356 (not shown) grown in the presence of 4-CB. Metabolites having a structure similar to metabolite 6 were also detected when other chlorobiphenyls were used as substrates. Metabolite 6 was produced from MCP since it was also detected in resting cell suspensions of P. putida DA2 or KT2440
and of E. coli DA251 incubated with 0.5 pmol MCP per 10 ml. Table 1 . The structure of metabolite 6 is presented in Fig. 4 .
From the mass-spectral characteristics of metabolite 6-TMS (Fig. 4) , it was tentatively identified as the 2-picolinic acid derivative of MCP. The TMS derivative exhibits a molecular ion at m/z 305 and fragment ions at m/z 290 (M-CH3), 277 (M-CO), 188 (M-CO-TMS), 153 (M-CO-TMS-Cl), 127 (M-CO-TMS-Cl-NC), which are in accordance with the proposed structure.
Further evidence for the structure of metabolite 6 was provided from the observation that in the presence of 6 M-NH,OH, MCP was converted into a derivative with retention time and mass spectral characteristics identical to metabolite 6 detected in the culture broth of cells grown with 4-CB. Such a conversion into a 2-picolinic acid derivative has also been observed in the case of the meta-cleavage product generated from 3,4-dihydroxy-9,lO-secoandrost a-1 ,3,5, ( 1 0), triene-9,17-d ione (Gibson et al., 1966) and in the case of 2-hydroxy-6-carboxymuconate semi-aldehyde, which is the meta-cleavage product of protocatechuate (Rossi & Shing, 1948) , when these compounds were incubated in 6 M-ammoniacal solution. Since in these two examples, the cleavage occurs in a manner analogous to 2,3-OH-4'-CBP, resulting in the formation of an acidic metabolite possessing a 2-hydroxy-6-oxo-hexa-2,4-dienoic moiety, the mechanism of formation of metabolite 6 when MCP is incubated in ammoniacal solution is probably similar. In order to further understand the interrelationship between the various acidic derivatives of 4-CB, HPLCpurified DS-MCP was fed to cell suspensions of strains B-356, DA 1, DA2 and KT2440. These suspensions were incubated for either 18 or 48 h. Part of the results are given in Table 3 . P. testosteroni strain B-356 rapidly converted DS-MCP -70% of the substrate disappeared within 18 h of incubation; metabolites 6 and 8 were the major products of this conversion. In 48 h old cultures, metabolites 7 and 8 had completely disappeared and metabolites 1 to 6 were all detected. Table 4 . Production of metabolites from non-purijied P. putida DA-2 was incubated for 48 h in MM 30 plus 0.1 % 4-CB.
The culture was extracted at neutral pH with ethyl acetate, acidified at pH 3 then extracted again with ethyl acetate. The acid extract contained large amounts of DS-MCP with small amounts of metabolites 1, 3 and 4. Resting cell suspensions of strains KT2440 and B-356 were prepared from exponential-phase cultures, and were adjusted to an ODboo of 1. Suspensions (25 ml) were fed 60 pg of the acid extract, containing 210 pmol DS-MCP, then incubated for 18 h at 29 "C followed by extraction at pH 3 with ethyl acetate. t Culture medium plus DS-MCP incubated without bacterial cells.
DS-MCP
All three P . putida strains tested were also able to carry out this transformation, but the rate of transformation was slower than in the case of P . testosteroni strain B-356 (Table 3 ). All three strains produced approximately equal amounts of metabolites 2, 3, 4, 5 and 6, which slowly increased with time, suggesting that these reactions are controlled by genes carried by the host strain P . putida KT2440.
One interesting observation is that a trace amount of MS-MCP (metabolite 8) was detected in cultures of DA 1 grown with DS-MCP (Table 3) . In further experiments using as substrate an acidic extract of DA2 cultures grown with 4-CB, DS-MCP, which was the major component of the extract, was rapidly converted into MS-MCP and metabolite 6 by both P . testosteroni B-356 and P . putida KT2440 (Table 4 ). It is noteworthy that unpurified DS-MCP was transformed into MS-MCP as fast in strain KT2440 as in strain B-356. Some undetected regulatory factor present in culture extracts of strain DA2 could possibly be controlling this transformat ion.
The important point about these experiments is that they clearly show that DS-MCP is transformed into MS-MCP and metabolite 6. The fact that metabolite 6 is derived from MCP shows that DS-MCP can be converted back into MS-MCP and MCP. Since hydrolysis or oxidative decarboxylation of aliphatic carbon chains cannot occur directly on a reduced chain, it is not surprising that transformation of DS-MCP into metabolites 2, 3, 4 and 5 included an oxidative step converting DS-MCP back into MS-MCP and/or MCP. Moreover, analysis of controls of DS-MCP, MS-MCP and MCP without cells clearly shows that the production of these acids occurs through a biological process. Hence, MS-MCP and DS-MCP seem to be very stable and under neutral conditions are not spontaneously cleaved to compounds with a shorter acidic side chain. When 0.5 pmol purified MCP was dissolved in distilled water, the A434 remained stable for at least 7 h. However, although 100% of MCP was re-extracted immediately after solubilization of the compound in water, when analysed by GC/MS, the amount of MCP recovered decreased with the time of incubation. After 2 h, 75% of the added MCP was re-extracted, and after 7 h, only 35 % was recovered. However, as shown in Fig. 5 , metabolites 2, 3, 4 and 5 were not detected in these preparations. MCP was also solubilized in MM 30 and in 0.1 Mphosphate buffer pH 7.0, and similar results were observed. Therefore, when MCP was incubated in aqueous solution under neutral conditions, it was converted to unrecoverable coloured derivatives, possibly polymers as suggested by Catelani et al. (1973) , that j 5 40 were neither detected by GC/MS analysis nor were cleaved spontaneously to benzoyl compounds with a shorter acidic side chain.
Discussion
The pathway shown in Fig. 1 summarizes the various enzymic steps presumed to be involved in the catabolism of biphenyls and chlorobiphenyls. This pathway was deduced from analysis of metabolites produced from the biphenyl substrates (Catelani et af., 1973; Ahmed & Focht, 1973; Furukawa & Matsumura, 1976; Omori et al., 1986b; Ishigooka et af., 1986) and it was further supported by recent cloning of the genes controlling these enzymes (Mondello, 1989 , 1986b) . However, very little information on the step-by-step reactions occurring in these pathways, or on their relative importance in the metabolism of biphenyls, is available. For example, it was postulated that the initiation of oxidation of the biphenyl molecule through a 3,4-dihydroxylation step is a prerequisite for the degradation of some PCB congeners (Bedard et af., 1987) . However, although 3,4-dihydro-3,4-dihydroxychlorobiphenyls and possible metabolites deriving from it have been detected in some bacterial cultures (MassC et al, 1989; Nadim et af., 1987), details of the transformation steps are still unknown.
In the present work, using bacterial clones carrying only part of the PCB degradation pathway, we have determined the origin of formation of some of the acidic metabolites that have been encountered in many bacterial cultures grown in the presence of chlorobiphenyls (Mass6 et al., 1984,1989 ). Using 4-CB as a model, we have shown that MCP deriving from it is rapidly converted into derivathes with mono-and di-saturated side chains. The genes responsible for this conversion are not part of the bph operon, and are found in the host strain P. putida KT2440 which is unable to degrade biphenyl. DS-MCP can be re-oxidized and then cleaved to generate acid metabolites with a shorter aliphatic side chain. It is interesting that these biotransformation reactions are very efficient in strain B-356, where all saturated MCP added was degraded into other acidic derivatives within 48 h ( Table 3) . It has previously been shown that 4-CBA affects the regulation of the BP/PCB degradation pathway, where accumulation of 4-CBA favours the production of acidic metabolites that are unexpected as intermediates of this pathway (Sylvestre
